New Therapeutic Strategy for Parkinson's and Alzheimer's Disease

E-ISSN： 1875-533x|17|25|2764-2774

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.25, 2010-09, pp. : 2764-2774

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

By Castro A. Martinez A.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 693-702

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4936-4947

Bentham Science Publishers

Access to resources Recommend Favorite

New therapeutic patents for Alzheimer’s disease

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1751-1757

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 17, Iss. 8, 2018-10 ,pp. : 571-589

Bentham Science Publishers

Access to resources Recommend Favorite